Published in Exp Cell Res on November 25, 1997
The contribution of growth hormone to mammary neoplasia. J Mammary Gland Biol Neoplasia (2008) 0.90
The oncogenic potential of autocrine human growth hormone in breast cancer. Proc Natl Acad Sci U S A (2004) 0.82
Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy? Indian J Clin Biochem (2012) 0.76
Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. Cell Immunol (2013) 0.76
The paracrine effect of exogenous growth hormone alleviates dysmorphogenesis caused by tbx5 deficiency in zebrafish (Danio rerio) embryos. J Biomed Sci (2012) 0.75
Correlation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response. Indian J Clin Biochem (2013) 0.75
Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling. Biosci Rep (2012) 0.75
Metallothionein-human GH fusion genes stimulate growth of mice. Science (1983) 4.03
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell (1996) 3.60
Regulation, linkage, and sequence of mouse metallothionein I and II genes. Mol Cell Biol (1984) 3.25
Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A (1999) 2.62
Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J (1995) 2.00
Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell (1984) 1.61
Sex steroid induced changes in hepatic enzymes. Annu Rev Physiol (1983) 1.54
Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci U S A (1986) 1.37
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci U S A (1992) 1.34
Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest (1997) 1.31
The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol Endocrinol (1996) 1.28
Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer (1998) 1.25
Constitutive nuclear localization of Janus kinases 1 and 2. Endocrinology (1996) 1.23
Signal transduction via the growth hormone receptor. Cell Signal (2001) 1.22
The role of prolactin and growth hormone in breast cancer. Oncogene (2000) 1.20
Transcriptional activation of p53 by Pitx1. Cell Death Differ (2007) 1.15
Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology (1997) 1.12
Regulation of sexual differentiation in drug and steroid metabolism. Trends Pharmacol Sci (1989) 1.12
Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids. Mol Endocrinol (1988) 1.11
Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem (1994) 1.10
Nuclear translocation and anchorage of the growth hormone receptor. J Biol Chem (1994) 1.08
Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology (1989) 1.08
Gene expression profile of the aging process in rat liver: normalizing effects of growth hormone replacement. Mol Endocrinol (2001) 1.06
Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells. Mol Endocrinol (1989) 1.06
Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun (1998) 1.05
Regulation of rat growth hormone receptor gene expression. J Biol Chem (1989) 1.05
Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. Br J Cancer (2003) 1.05
High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland. J Endocrinol (2002) 1.05
Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma. Oncogene (2010) 1.05
HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene (2007) 1.05
Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology (1981) 1.05
Artemin is oncogenic for human mammary carcinoma cells. Oncogene (2009) 1.04
Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes (2001) 1.04
Ezrin mediates c-Myc actions in prostate cancer cell invasion. Oncogene (2009) 1.04
Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. Biochem Biophys Res Commun (2000) 1.03
Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology (1999) 1.02
Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5. J Biol Chem (1995) 1.01
Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J Biol Chem (1995) 0.99
DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene (2007) 0.98
Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem (1996) 0.98
The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology (2001) 0.98
The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obes Rev (2000) 0.97
Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9 A resolution. J Biol Chem (1996) 0.97
Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? Development (1992) 0.96
Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol (1989) 0.96
Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas. Endocrine (2000) 0.96
Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology (2001) 0.96
Differing expression of insulin-like growth factor I in the developing and in the adult rat cerebellum. Acta Physiol Scand (1988) 0.96
Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Exp Cell Res (1999) 0.95
Vascular function and blood pressure in GH transgenic mice. Endocrinology (2001) 0.95
Growth hormone specifically regulates serine protease inhibitor gene transcription via gamma-activated sequence-like DNA elements. J Biol Chem (1994) 0.94
Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. Endocrinology (1988) 0.94
Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. J Biol Chem (1992) 0.94
Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone. Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis. J Biol Chem (2000) 0.94
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am J Physiol Endocrinol Metab (2001) 0.93
Caveolar internalization of growth hormone. Exp Cell Res (1999) 0.93
Growth hormone receptor is expressed in human breast cancer. Am J Pathol (2001) 0.93
Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: correlation with myotube formation. Mol Endocrinol (1992) 0.92
Growth hormone as a cytokine. Clin Exp Pharmacol Physiol (1999) 0.91
Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem (1998) 0.91
Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology (2000) 0.90
Identification of phenylalanine 346 in the rat growth hormone receptor as being critical for ligand-mediated internalization and down-regulation. J Biol Chem (1995) 0.89
Growth hormone (GH) stimulates protein synthesis in cells transfected with GH receptor complementary DNA. Mol Endocrinol (1990) 0.89
Receptor-mediated nuclear translocation of growth hormone. J Biol Chem (1994) 0.89
Role of pituitary hormones on 17alpha-ethinylestradiol-induced cholestasis in rat. J Pharmacol Exp Ther (2006) 0.89
Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. Fak is not required for stat-mediated transcription. J Biol Chem (1998) 0.88
Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter. Mol Cell Endocrinol (1997) 0.87
Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival. J Biol Chem (2001) 0.86
Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Endocrinology (1998) 0.86
Evidence for association of the cloned liver growth hormone receptor with a tyrosine kinase. J Biol Chem (1992) 0.86
In situ reverse transcription-polymerase chain reaction. Applications for light and electron microscopy. Biol Cell (1998) 0.86
Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5. Mol Cell Endocrinol (1997) 0.85
Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells. J Endocrinol (1990) 0.85
Purification of liver feminizing factor from rat pituitaries and demonstration of its identity with growth hormone. Endocrinology (1983) 0.85
Multihormonal regulation of the estrogen receptor in rat liver. Endocrinology (1981) 0.85
Different effects of cyclic nucleotide derivatives upon the rat oocyte-cumulus complex in vitro. Acta Physiol Scand (1984) 0.84
Introduction of exogenous growth hormone receptors augments growth hormone-responsive insulin biosynthesis in rat insulinoma cells. Proc Natl Acad Sci U S A (1990) 0.84
Endocrine regulation of longitudinal bone growth. Acta Paediatr Suppl (1993) 0.84
GH substitution reverses the growth phenotype but not the defective ossification in thyroid hormone receptor alpha 1-/-beta-/- mice. J Endocrinol (2001) 0.83
Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent. Endocrinology (2000) 0.83
Regulation of sexually dimorphic hepatic steroid metabolism by the somatostatin-growth hormone axis. J Steroid Biochem (1983) 0.83
Characterization and subcellular distribution of somatogenic receptor in rat liver. Endocrinology (1985) 0.82
Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver. J Steroid Biochem Mol Biol (1994) 0.82
Insulin-like growth factor I in the pancreas of normal and diabetic adult rats. Acta Physiol Scand (1988) 0.82
Developmental and steroid hormonal regulation of insulin-like growth factor II expression. Mol Endocrinol (1989) 0.82
Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis. Cancer Lett (2012) 0.81
Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice. Endocrinology (1994) 0.81
Decreased expression of the growth hormone receptor and growth hormone binding protein in rat liver nodules. Mol Carcinog (1990) 0.81
Central control of prolactin and estrogen receptors in rat liver--expression of a novel endocrine system, the hypothalamo-pituitary-liver axis. Annu Rev Pharmacol Toxicol (1983) 0.81